If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> VOLUME 110 NUMBER 1 JANUARY 2015<br /> www.amjgastro.com<br /> OFFICIAL PUBLICATION OF THE AMERICAN COLLEGE OF GASTROENTEROLOGY<br /> LEADING ARTICLES OF THE MONTH<br /> Practice Guidelines<br /> 18 ACG Clinical Guidelines: Epidemiology, Risk Factors,<br /> Patterns of Presentation, Diagnosis, and Management<br /> of Colon Ischemia (CI) CME<br /> L.J. Brandt, P. Feuerstadt, G.F. Longstreth and S.J. Boley<br /> Quality Indicators for GI Endoscopic Procedures<br /> 60 Quality Indicators for EGD<br /> W.G. Park, N.J. Shaheen, J. Cohen, I.M. Pike, D.G. Adler, J.M. Inadomi,<br /> L.A. Laine, J.G. Lieb II, M.K. Rizk, M.S. Sawhney and S. Wani<br /> 72 Quality Indicators for Colonoscopy<br /> D.K. Rex, P.S. Schoenfeld, J. Cohen, I.M. Pike, D.G. Adler, M.B. Fennerty,<br /> J.G. Lieb II, W.G. Park, M.K. Rizk, M.S. Sawhney, N.J. Shaheen, S.<a title="AJG_Vol.110.No.9 page 1" href="http://viewer.zmags.com/publication/8978fbb9?page=1"> ARCHIVE VOLUME 110 NUMBER 1 JANUARY 2015 www.am</a> <a title="AJG_Vol.110.No.9 page 2" href="http://viewer.zmags.com/publication/8978fbb9?page=2"> VOLUME 110 NUMBER 9 SEPTEMBER 2015 www.nature.c</a> <a title="AJG_Vol.110.No.9 page 3" href="http://viewer.zmags.com/publication/8978fbb9?page=3"> * *by patients in clinical trials† </a> <a title="AJG_Vol.110.No.9 page 4" href="http://viewer.zmags.com/publication/8978fbb9?page=4"> Split-dose Prepopik demonstrated‡: EFFE</a> <a title="AJG_Vol.110.No.9 page 5" href="http://viewer.zmags.com/publication/8978fbb9?page=5"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.110.No.9 page 6" href="http://viewer.zmags.com/publication/8978fbb9?page=6"> Looking for an easy way to diagnose SIBO? %</a> <a title="AJG_Vol.110.No.9 page 7" href="http://viewer.zmags.com/publication/8978fbb9?page=7"> www.amjgastro.com The American Journa</a> <a title="AJG_Vol.110.No.9 page 8" href="http://viewer.zmags.com/publication/8978fbb9?page=8"> BRIEF SUMMARY UCERIS (budesonide) extended releas</a> <a title="AJG_Vol.110.No.9 page 9" href="http://viewer.zmags.com/publication/8978fbb9?page=9"> In active, mild to moderate ulcerative colitis (U</a> <a title="AJG_Vol.110.No.9 page 10" href="http://viewer.zmags.com/publication/8978fbb9?page=10"> OFFICIAL PUBLICATION OF THE AMERICAN CO</a> <a title="AJG_Vol.110.No.9 page 11" href="http://viewer.zmags.com/publication/8978fbb9?page=11"> GI QUALITY IMPROVEMENT CONSORTIUM LTD 3 Se ing </a> <a title="AJG_Vol.110.No.9 page 12" href="http://viewer.zmags.com/publication/8978fbb9?page=12"> Personality rights of Thomas Edison are used with</a> <a title="AJG_Vol.110.No.9 page 13" href="http://viewer.zmags.com/publication/8978fbb9?page=13"> HARVONI IS THE FIRST AND ONLY SINGLE-TABLET REGIM</a> <a title="AJG_Vol.110.No.9 page 14" href="http://viewer.zmags.com/publication/8978fbb9?page=14"> FOR TREATING CHRONIC HCV GT 1 BE THE ONE WHO CAN</a> <a title="AJG_Vol.110.No.9 page 15" href="http://viewer.zmags.com/publication/8978fbb9?page=15"> HARVONI® (ledipasvir 90 mg and sofosbuvir 400 mg)</a> <a title="AJG_Vol.110.No.9 page 16" href="http://viewer.zmags.com/publication/8978fbb9?page=16"> Brief Summary (cont.) · Proton-pump inhibitors: </a> <a title="AJG_Vol.110.No.9 page 17" href="http://viewer.zmags.com/publication/8978fbb9?page=17"> For patients with</a> <a title="AJG_Vol.110.No.9 page 18" href="http://viewer.zmags.com/publication/8978fbb9?page=18"> To request samples, call 1-800-828-2845 or visit </a> <a title="AJG_Vol.110.No.9 page 19" href="http://viewer.zmags.com/publication/8978fbb9?page=19"> BRIEF SUMMARY: Consult the Full Prescribing Infor</a> <a title="AJG_Vol.110.No.9 page 20" href="http://viewer.zmags.com/publication/8978fbb9?page=20"> not always possible to reliably estimate their fr</a> <a title="AJG_Vol.110.No.9 page 21" href="http://viewer.zmags.com/publication/8978fbb9?page=21"> american college of gastroenterology ACG2015 Annu</a> <a title="AJG_Vol.110.No.9 page 22" href="http://viewer.zmags.com/publication/8978fbb9?page=22"> BRIEF SUMMARY OF PRESCRIBING INFORMATION This Bri</a> <a title="AJG_Vol.110.No.9 page 23" href="http://viewer.zmags.com/publication/8978fbb9?page=23"> NEW IBS-D INDICATION Now approved for the treatm</a> <a title="AJG_Vol.110.No.9 page 24" href="http://viewer.zmags.com/publication/8978fbb9?page=24"> A 48-year-old woman presented with a 20-year hist</a> <a title="AJG_Vol.110.No.9 page 25" href="http://viewer.zmags.com/publication/8978fbb9?page=25"> CONTENTS </a> <a title="AJG_Vol.110.No.9 page 26" href="http://viewer.zmags.com/publication/8978fbb9?page=26"> www.nature.com/ajg </a> <a title="AJG_Vol.110.No.9 page 27" href="http://viewer.zmags.com/publication/8978fbb9?page=27"> Order Free Postcards for Your Practice ULCERATIV</a> <a title="AJG_Vol.110.No.9 page 28" href="http://viewer.zmags.com/publication/8978fbb9?page=28"> MAKE THE MOVE APRISO SAVINGS PROGRAM $0 $</a> <a title="AJG_Vol.110.No.9 page 29" href="http://viewer.zmags.com/publication/8978fbb9?page=29"> The following is a brief summary only. See comple</a> <a title="AJG_Vol.110.No.9 page 30" href="http://viewer.zmags.com/publication/8978fbb9?page=30"> For the management of chronic loose and frequent </a> <a title="AJG_Vol.110.No.9 page 31" href="http://viewer.zmags.com/publication/8978fbb9?page=31"> BRIEF SUMMARY Please see package insert for Full </a> <a title="AJG_Vol.110.No.9 page 32" href="http://viewer.zmags.com/publication/8978fbb9?page=32"> YOUR LAB EQUIPMENT RESOURCE nature.com/marketplac</a> <a title="AJG_Vol.110.No.9 page 33" href="http://viewer.zmags.com/publication/8978fbb9?page=33"> INDICATION AND IMPORTANT SAFETY INFORMATION FOR H</a> <a title="AJG_Vol.110.No.9 page 34" href="http://viewer.zmags.com/publication/8978fbb9?page=34"> Achieve UC remission— </a> <a title="AJG_Vol.110.No.9 page 35" href="http://viewer.zmags.com/publication/8978fbb9?page=35"> HUMIRA® (adalimumab) </a> <a title="AJG_Vol.110.No.9 page 36" href="http://viewer.zmags.com/publication/8978fbb9?page=36"> Autoimmunity Treatment with HUMIRA may result in </a> <a title="AJG_Vol.110.No.9 page 37" href="http://viewer.zmags.com/publication/8978fbb9?page=37"> Skin reactions: Stevens Johnson Syndrome, cutaneo</a> <a title="AJG_Vol.110.No.9 page 38" href="http://viewer.zmags.com/publication/8978fbb9?page=38"> Unique events committed to scientific excellence </a> <a title="AJG_Vol.110.No.9 page 39" href="http://viewer.zmags.com/publication/8978fbb9?page=39"> Evolving science communication It's always been o</a> <a title="AJG_Vol.110.No.9 page 40" href="http://viewer.zmags.com/publication/8978fbb9?page=40"> Intercept Pharmaceuticals is focused on innova</a> <a title="AJG_Vol.110.No.9 page 41" href="http://viewer.zmags.com/publication/8978fbb9?page=41"> Brought to you by the American College of Gastroe</a> <a title="AJG_Vol.110.No.9 page 42" href="http://viewer.zmags.com/publication/8978fbb9?page=42"> TURNING RESEARCH INTO RECOVERY — FASTER. THAT'S T</a> <a title="AJG_Vol.110.No.9 page 43" href="http://viewer.zmags.com/publication/8978fbb9?page=43"> Download the NatureJournals app for iPad, iPhone </a> <a title="AJG_Vol.110.No.9 page 44" href="http://viewer.zmags.com/publication/8978fbb9?page=44"> In active, mild to moderate ulcerative colitis (U</a> <a title="AJG_Vol.110.No.9 page 45" href="http://viewer.zmags.com/publication/8978fbb9?page=45"> BRIEF SUMMARY UCERIS (budesonide) extended releas</a> <a title="AJG_Vol.110.No.9 page 46" href="http://viewer.zmags.com/publication/8978fbb9?page=46"> RULE OUT LAL D! </a> <a title="AJG_Vol.110.No.9 page 47" href="http://viewer.zmags.com/publication/8978fbb9?page=47"> NEW Clinical Evidence Supports a New Ap</a> <a title="AJG_Vol.110.No.9 page 48" href="http://viewer.zmags.com/publication/8978fbb9?page=48"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 49" href="http://viewer.zmags.com/publication/8978fbb9?page=49"> 1250 THE RED SECTION </a> <a title="AJG_Vol.110.No.9 page 50" href="http://viewer.zmags.com/publication/8978fbb9?page=50"> THE RED SECTION 1251 is suggestive</a> <a title="AJG_Vol.110.No.9 page 51" href="http://viewer.zmags.com/publication/8978fbb9?page=51"> 1252 THE RED SECTION </a> <a title="AJG_Vol.110.No.9 page 52" href="http://viewer.zmags.com/publication/8978fbb9?page=52"> THE RED SECTION 1253 Symptomatic patient </a> <a title="AJG_Vol.110.No.9 page 53" href="http://viewer.zmags.com/publication/8978fbb9?page=53"> 1254 THE RED SECTION newer management st</a> <a title="AJG_Vol.110.No.9 page 54" href="http://viewer.zmags.com/publication/8978fbb9?page=54"> IBD patient refusal of recommended treatments</a> <a title="AJG_Vol.110.No.9 page 55" href="http://viewer.zmags.com/publication/8978fbb9?page=55"> 1256 THE RED SECTION management approach</a> <a title="AJG_Vol.110.No.9 page 56" href="http://viewer.zmags.com/publication/8978fbb9?page=56"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 57" href="http://viewer.zmags.com/publication/8978fbb9?page=57"> 1258 THE RED SECTION </a> <a title="AJG_Vol.110.No.9 page 58" href="http://viewer.zmags.com/publication/8978fbb9?page=58"> Table 1. Kappa values among pathologists in the d</a> <a title="AJG_Vol.110.No.9 page 59" href="http://viewer.zmags.com/publication/8978fbb9?page=59"> 1260 THE RED SECTION esophageal candida </a> <a title="AJG_Vol.110.No.9 page 60" href="http://viewer.zmags.com/publication/8978fbb9?page=60"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 61" href="http://viewer.zmags.com/publication/8978fbb9?page=61"> 1262 THE RED SECTION </a> <a title="AJG_Vol.110.No.9 page 62" href="http://viewer.zmags.com/publication/8978fbb9?page=62"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 63" href="http://viewer.zmags.com/publication/8978fbb9?page=63"> 1264 PRACTICE GUIDELINES </a> <a title="AJG_Vol.110.No.9 page 64" href="http://viewer.zmags.com/publication/8978fbb9?page=64"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 65" href="http://viewer.zmags.com/publication/8978fbb9?page=65"> 1266 Gerson et al. Table 1. Recommendati</a> <a title="AJG_Vol.110.No.9 page 66" href="http://viewer.zmags.com/publication/8978fbb9?page=66"> Guidelines for Small Bowel Bleeding 1267 </a> <a title="AJG_Vol.110.No.9 page 67" href="http://viewer.zmags.com/publication/8978fbb9?page=67"> 1268 Gerson et al. Suspected small bowel</a> <a title="AJG_Vol.110.No.9 page 68" href="http://viewer.zmags.com/publication/8978fbb9?page=68"> Table 2. Causes of small bowel bleeding Common ca</a> <a title="AJG_Vol.110.No.9 page 69" href="http://viewer.zmags.com/publication/8978fbb9?page=69"> 1270 Gerson et al. clues to the underl</a> <a title="AJG_Vol.110.No.9 page 70" href="http://viewer.zmags.com/publication/8978fbb9?page=70"> stomach and stiffen the enteroscope for deeper pa</a> <a title="AJG_Vol.110.No.9 page 71" href="http://viewer.zmags.com/publication/8978fbb9?page=71"> 1272 Gerson et al. To perform DBE, </a> <a title="AJG_Vol.110.No.9 page 72" href="http://viewer.zmags.com/publication/8978fbb9?page=72"> yield of the initial cases of spiral enteroscopy </a> <a title="AJG_Vol.110.No.9 page 73" href="http://viewer.zmags.com/publication/8978fbb9?page=73"> 1274 Gerson et al. The indications </a> <a title="AJG_Vol.110.No.9 page 74" href="http://viewer.zmags.com/publication/8978fbb9?page=74"> small number of studies regarding MR enterography</a> <a title="AJG_Vol.110.No.9 page 75" href="http://viewer.zmags.com/publication/8978fbb9?page=75"> 1276 Gerson et al. Scintigraphy 99mTc-</a> <a title="AJG_Vol.110.No.9 page 76" href="http://viewer.zmags.com/publication/8978fbb9?page=76"> in 48% of patients and allowed embolization in 45</a> <a title="AJG_Vol.110.No.9 page 77" href="http://viewer.zmags.com/publication/8978fbb9?page=77"> 1278 Gerson et al. centers between 200</a> <a title="AJG_Vol.110.No.9 page 78" href="http://viewer.zmags.com/publication/8978fbb9?page=78"> were consecutive patients who had been bleeding f</a> <a title="AJG_Vol.110.No.9 page 79" href="http://viewer.zmags.com/publication/8978fbb9?page=79"> 1280 Gerson et al. for patients in who</a> <a title="AJG_Vol.110.No.9 page 80" href="http://viewer.zmags.com/publication/8978fbb9?page=80"> 42. Rondonotti E, Villa F, Mulder CJ et al. Smal</a> <a title="AJG_Vol.110.No.9 page 81" href="http://viewer.zmags.com/publication/8978fbb9?page=81"> 1282 Gerson et al. 92. Byeon JS, Mann</a> <a title="AJG_Vol.110.No.9 page 82" href="http://viewer.zmags.com/publication/8978fbb9?page=82"> 143. Gerson L, Kamal A. Cost-effectiveness analys</a> <a title="AJG_Vol.110.No.9 page 83" href="http://viewer.zmags.com/publication/8978fbb9?page=83"> 1284 Gerson et al. 193. Kim CY, Suhock</a> <a title="AJG_Vol.110.No.9 page 84" href="http://viewer.zmags.com/publication/8978fbb9?page=84"> Guidelines for Small Bowel Bleeding 1285 </a> <a title="AJG_Vol.110.No.9 page 85" href="http://viewer.zmags.com/publication/8978fbb9?page=85"> 1286 Gerson et al. (41) limit 39 to</a> <a title="AJG_Vol.110.No.9 page 86" href="http://viewer.zmags.com/publication/8978fbb9?page=86"> Guidelines for Small Bowel Bleeding 1287 </a> <a title="AJG_Vol.110.No.9 page 87" href="http://viewer.zmags.com/publication/8978fbb9?page=87"> 1288 PRACTICE GUIDELINES </a> <a title="AJG_Vol.110.No.9 page 88" href="http://viewer.zmags.com/publication/8978fbb9?page=88"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 89" href="http://viewer.zmags.com/publication/8978fbb9?page=89"> 1290 van Rhijn et al. ESOPHAGUS Very r</a> <a title="AJG_Vol.110.No.9 page 90" href="http://viewer.zmags.com/publication/8978fbb9?page=90"> Biopsy specimens were homogenized and total RNA w</a> <a title="AJG_Vol.110.No.9 page 91" href="http://viewer.zmags.com/publication/8978fbb9?page=91"> 1292 van Rhijn et al. a 150 100 </a> <a title="AJG_Vol.110.No.9 page 92" href="http://viewer.zmags.com/publication/8978fbb9?page=92"> Fluticasone Propionate Improves Mucosal Barrier I</a> <a title="AJG_Vol.110.No.9 page 93" href="http://viewer.zmags.com/publication/8978fbb9?page=93"> 1294 van Rhijn et al. a </a> <a title="AJG_Vol.110.No.9 page 94" href="http://viewer.zmags.com/publication/8978fbb9?page=94"> Table 3. Esophageal mucosal integrity and eosinop</a> <a title="AJG_Vol.110.No.9 page 95" href="http://viewer.zmags.com/publication/8978fbb9?page=95"> 1296 van Rhijn et al. ESOPHAGUS suggest th</a> <a title="AJG_Vol.110.No.9 page 96" href="http://viewer.zmags.com/publication/8978fbb9?page=96"> REFERENCES 1. van Rhijn BD, Verheij J, Smout AJ </a> <a title="AJG_Vol.110.No.9 page 97" href="http://viewer.zmags.com/publication/8978fbb9?page=97"> 1298 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.9 page 98" href="http://viewer.zmags.com/publication/8978fbb9?page=98"> patients with NAFLD. Both clinicians and patients</a> <a title="AJG_Vol.110.No.9 page 99" href="http://viewer.zmags.com/publication/8978fbb9?page=99"> 1300 Tapper et al. Return to prima</a> <a title="AJG_Vol.110.No.9 page 100" href="http://viewer.zmags.com/publication/8978fbb9?page=100"> Table 1. Estimates of test performance and diseas</a> <a title="AJG_Vol.110.No.9 page 101" href="http://viewer.zmags.com/publication/8978fbb9?page=101"> 1302 Tapper et al. LIVER of 10,000 patient</a> <a title="AJG_Vol.110.No.9 page 102" href="http://viewer.zmags.com/publication/8978fbb9?page=102"> combination of NFS with VCTE, will allow gastroen</a> <a title="AJG_Vol.110.No.9 page 103" href="http://viewer.zmags.com/publication/8978fbb9?page=103"> 1304 Tapper et al. money was received </a> <a title="AJG_Vol.110.No.9 page 104" href="http://viewer.zmags.com/publication/8978fbb9?page=104"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 105" href="http://viewer.zmags.com/publication/8978fbb9?page=105"> 1306 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.9 page 106" href="http://viewer.zmags.com/publication/8978fbb9?page=106"> NAFLD is more common in obese patients. Nonethe</a> <a title="AJG_Vol.110.No.9 page 107" href="http://viewer.zmags.com/publication/8978fbb9?page=107"> 1308 Wei et al. LIVER Five clinical pre</a> <a title="AJG_Vol.110.No.9 page 108" href="http://viewer.zmags.com/publication/8978fbb9?page=108"> Non-Obese Fatty Liver 1309 Table 1. Clini</a> <a title="AJG_Vol.110.No.9 page 109" href="http://viewer.zmags.com/publication/8978fbb9?page=109"> 1310 Wei et al. LIVER Table 2. Clinical ch</a> <a title="AJG_Vol.110.No.9 page 110" href="http://viewer.zmags.com/publication/8978fbb9?page=110"> IHTG (%) 50 40 30 20 10 0 P <0.001 </a> <a title="AJG_Vol.110.No.9 page 111" href="http://viewer.zmags.com/publication/8978fbb9?page=111"> 1312 Wei et al. LIVER Table 3. Factors ass</a> <a title="AJG_Vol.110.No.9 page 112" href="http://viewer.zmags.com/publication/8978fbb9?page=112"> could provide a complete picture of non-obese NAF</a> <a title="AJG_Vol.110.No.9 page 113" href="http://viewer.zmags.com/publication/8978fbb9?page=113"> 1314 Wei et al. LIVER significance </a> <a title="AJG_Vol.110.No.9 page 114" href="http://viewer.zmags.com/publication/8978fbb9?page=114"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 115" href="http://viewer.zmags.com/publication/8978fbb9?page=115"> 1316 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.9 page 116" href="http://viewer.zmags.com/publication/8978fbb9?page=116"> drawbacks limiting their accuracy in monitoring o</a> <a title="AJG_Vol.110.No.9 page 117" href="http://viewer.zmags.com/publication/8978fbb9?page=117"> 1318 Kopylov et al. Underwent MRE n=81 </a> <a title="AJG_Vol.110.No.9 page 118" href="http://viewer.zmags.com/publication/8978fbb9?page=118"> months). Current medical treatment of CD and even</a> <a title="AJG_Vol.110.No.9 page 119" href="http://viewer.zmags.com/publication/8978fbb9?page=119"> 1320 Kopylov et al. LS>135 ROC Curve 1</a> <a title="AJG_Vol.110.No.9 page 120" href="http://viewer.zmags.com/publication/8978fbb9?page=120"> monitoring with inflammatory biomarkers provides </a> <a title="AJG_Vol.110.No.9 page 121" href="http://viewer.zmags.com/publication/8978fbb9?page=121"> 1322 Kopylov et al. INFLAMMATORY BOWEL DISE</a> <a title="AJG_Vol.110.No.9 page 122" href="http://viewer.zmags.com/publication/8978fbb9?page=122"> 35. Allez M, Lemann M, Bonnet J et al. Long term </a> <a title="AJG_Vol.110.No.9 page 123" href="http://viewer.zmags.com/publication/8978fbb9?page=123"> 1324 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.9 page 124" href="http://viewer.zmags.com/publication/8978fbb9?page=124"> Therapeutic Goals for Treat-to-Target in IBD </a> <a title="AJG_Vol.110.No.9 page 125" href="http://viewer.zmags.com/publication/8978fbb9?page=125"> 1326 Peyrin-Biroulet et al. INFLAMMATORY BO</a> <a title="AJG_Vol.110.No.9 page 126" href="http://viewer.zmags.com/publication/8978fbb9?page=126"> Therapeutic Goals for Treat-to-Target in IBD </a> <a title="AJG_Vol.110.No.9 page 127" href="http://viewer.zmags.com/publication/8978fbb9?page=127"> 1328 Peyrin-Biroulet et al. INFLAMMATORY BO</a> <a title="AJG_Vol.110.No.9 page 128" href="http://viewer.zmags.com/publication/8978fbb9?page=128"> modification of its definition, to include an i2a</a> <a title="AJG_Vol.110.No.9 page 129" href="http://viewer.zmags.com/publication/8978fbb9?page=129"> 1330 Peyrin-Biroulet et al. INFLAMMATORY BO</a> <a title="AJG_Vol.110.No.9 page 130" href="http://viewer.zmags.com/publication/8978fbb9?page=130"> ≤1, and by a decrease of 20 for the PUCAI, at lea</a> <a title="AJG_Vol.110.No.9 page 131" href="http://viewer.zmags.com/publication/8978fbb9?page=131"> 1332 Peyrin-Biroulet et al. INFLAMMATORY BO</a> <a title="AJG_Vol.110.No.9 page 132" href="http://viewer.zmags.com/publication/8978fbb9?page=132"> treating patients with IBD in clinical practice a</a> <a title="AJG_Vol.110.No.9 page 133" href="http://viewer.zmags.com/publication/8978fbb9?page=133"> 1334 Peyrin-Biroulet et al. INFLAMMATORY BO</a> <a title="AJG_Vol.110.No.9 page 134" href="http://viewer.zmags.com/publication/8978fbb9?page=134"> 14. Jürgens M, Mahachie John JM, Cleynen I et a</a> <a title="AJG_Vol.110.No.9 page 135" href="http://viewer.zmags.com/publication/8978fbb9?page=135"> 1336 Peyrin-Biroulet et al. INFLAMMATORY BO</a> <a title="AJG_Vol.110.No.9 page 136" href="http://viewer.zmags.com/publication/8978fbb9?page=136"> 112. Beck A, Bager P, Jensen PE et al. How fatigu</a> <a title="AJG_Vol.110.No.9 page 137" href="http://viewer.zmags.com/publication/8978fbb9?page=137"> 1338 Peyrin-Biroulet et al. INFLAMMATORY BO</a> <a title="AJG_Vol.110.No.9 page 138" href="http://viewer.zmags.com/publication/8978fbb9?page=138"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 139" href="http://viewer.zmags.com/publication/8978fbb9?page=139"> 1340 Ringel-Kulka et al. FUNCTIONAL GI DISO</a> <a title="AJG_Vol.110.No.9 page 140" href="http://viewer.zmags.com/publication/8978fbb9?page=140"> Altered Colonic Bacterial Fermentation in IBS </a> <a title="AJG_Vol.110.No.9 page 141" href="http://viewer.zmags.com/publication/8978fbb9?page=141"> 1342 Ringel-Kulka et al. GI DISORDERS FUNCT</a> <a title="AJG_Vol.110.No.9 page 142" href="http://viewer.zmags.com/publication/8978fbb9?page=142"> Altered Colonic Bacterial Fermentation in IBS </a> <a title="AJG_Vol.110.No.9 page 143" href="http://viewer.zmags.com/publication/8978fbb9?page=143"> 1344 Ringel-Kulka et al. FUNCTIONAL GI DISO</a> <a title="AJG_Vol.110.No.9 page 144" href="http://viewer.zmags.com/publication/8978fbb9?page=144"> the radiopaque marker method. There was a good ag</a> <a title="AJG_Vol.110.No.9 page 145" href="http://viewer.zmags.com/publication/8978fbb9?page=145"> 1346 Ringel-Kulka et al. FUNCTIONAL GI DISO</a> <a title="AJG_Vol.110.No.9 page 146" href="http://viewer.zmags.com/publication/8978fbb9?page=146"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 147" href="http://viewer.zmags.com/publication/8978fbb9?page=147"> 1348 Dellon et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.110.No.9 page 148" href="http://viewer.zmags.com/publication/8978fbb9?page=148"> the literature (5). In addition to eosinophilic c</a> <a title="AJG_Vol.110.No.9 page 149" href="http://viewer.zmags.com/publication/8978fbb9?page=149"> 1350 Dellon et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.110.No.9 page 150" href="http://viewer.zmags.com/publication/8978fbb9?page=150"> Table 2. Endoscopic and histological characterist</a> <a title="AJG_Vol.110.No.9 page 151" href="http://viewer.zmags.com/publication/8978fbb9?page=151"> 1352 Dellon et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.110.No.9 page 152" href="http://viewer.zmags.com/publication/8978fbb9?page=152"> drafting, critical revision. Spencer Rusin, Shann</a> <a title="AJG_Vol.110.No.9 page 153" href="http://viewer.zmags.com/publication/8978fbb9?page=153"> 1354 Dellon et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.110.No.9 page 154" href="http://viewer.zmags.com/publication/8978fbb9?page=154"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 155" href="http://viewer.zmags.com/publication/8978fbb9?page=155"> 1356 Liu et al. COLON/SMALL BOWEL opinion </a> <a title="AJG_Vol.110.No.9 page 156" href="http://viewer.zmags.com/publication/8978fbb9?page=156"> All asymptomatic average-risk patients with a pos</a> <a title="AJG_Vol.110.No.9 page 157" href="http://viewer.zmags.com/publication/8978fbb9?page=157"> 1358 Liu et al. COLON/SMALL BOWEL there ar</a> <a title="AJG_Vol.110.No.9 page 158" href="http://viewer.zmags.com/publication/8978fbb9?page=158"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 159" href="http://viewer.zmags.com/publication/8978fbb9?page=159"> 1360 P Giorgi Rossi et al. COLON/SMALL BOWE</a> <a title="AJG_Vol.110.No.9 page 160" href="http://viewer.zmags.com/publication/8978fbb9?page=160"> “Age and Period” and “Cohort” Approaches 1361</a> <a title="AJG_Vol.110.No.9 page 161" href="http://viewer.zmags.com/publication/8978fbb9?page=161"> 1362 P Giorgi Rossi et al. whereas the</a> <a title="AJG_Vol.110.No.9 page 162" href="http://viewer.zmags.com/publication/8978fbb9?page=162"> Standardized incidence rate (per 100,000) 400 3</a> <a title="AJG_Vol.110.No.9 page 163" href="http://viewer.zmags.com/publication/8978fbb9?page=163"> 1364 P Giorgi Rossi et al. COLON/SMALL BOWE</a> <a title="AJG_Vol.110.No.9 page 164" href="http://viewer.zmags.com/publication/8978fbb9?page=164"> with this method are diluted because of the inclu</a> <a title="AJG_Vol.110.No.9 page 165" href="http://viewer.zmags.com/publication/8978fbb9?page=165"> 1366 P Giorgi Rossi et al. COLON/SMALL BOWE</a> <a title="AJG_Vol.110.No.9 page 166" href="http://viewer.zmags.com/publication/8978fbb9?page=166"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 167" href="http://viewer.zmags.com/publication/8978fbb9?page=167"> 1368 Letters to the Editor </a> <a title="AJG_Vol.110.No.9 page 168" href="http://viewer.zmags.com/publication/8978fbb9?page=168"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 169" href="http://viewer.zmags.com/publication/8978fbb9?page=169"> 1370 Letters to the Editor </a> <a title="AJG_Vol.110.No.9 page 170" href="http://viewer.zmags.com/publication/8978fbb9?page=170"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 171" href="http://viewer.zmags.com/publication/8978fbb9?page=171"> 1372 Letters to the Editor </a> <a title="AJG_Vol.110.No.9 page 172" href="http://viewer.zmags.com/publication/8978fbb9?page=172"> nature publishing group </a> <a title="AJG_Vol.110.No.9 page 173" href="http://viewer.zmags.com/publication/8978fbb9?page=173"> 1374 REVIEWER RECOGNITION </a> <a title="AJG_Vol.110.No.9 page 174" href="http://viewer.zmags.com/publication/8978fbb9?page=174"> Anglin, Rebecca Angulo, Paul Asrani, Sumeet Aucej</a> <a title="AJG_Vol.110.No.9 page 175" href="http://viewer.zmags.com/publication/8978fbb9?page=175"> 1376 Hachem, Christine Hamilton, Matthew Ha</a> <a title="AJG_Vol.110.No.9 page 176" href="http://viewer.zmags.com/publication/8978fbb9?page=176"> Peterson, Kathryn Petrov, Maxim Peyrin-Biroulet, </a> <a title="AJG_Vol.110.No.9 page 177" href="http://viewer.zmags.com/publication/8978fbb9?page=177"> CLASSIFIEDS EUS Gastroenterologist Opportunity We</a> <a title="AJG_Vol.110.No.9 page 178" href="http://viewer.zmags.com/publication/8978fbb9?page=178"> Hawaii's Healthcare Leader Gastroenterolog</a> <a title="AJG_Vol.110.No.9 page 179" href="http://viewer.zmags.com/publication/8978fbb9?page=179"> Gastroenterology Call This Top 10 “Best Places to</a> <a title="AJG_Vol.110.No.9 page 180" href="http://viewer.zmags.com/publication/8978fbb9?page=180"> IMPORTANT SAFETY INFORMATION SUPREP® Bowel Prep K</a> <a title="AJG_Vol.110.No.9 page 181" href="http://viewer.zmags.com/publication/8978fbb9?page=181"> #1 MOST PRESCRIBED, BRANDED BOWEL PREP KIT1 </a>